Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation

被引：69

作者：

Delmas, PD

Rizzoli, R

Cooper, C

Reginster, JY

机构：

[1] Univ Lyon 1, Lyon, France

[2] INSERM, Res Unit 403, F-69008 Lyon, France

[3] Univ Geneva, CH-1211 Geneva 4, Switzerland

[4] Univ Southampton, Southampton SO9 5NH, Hants, England

[5] Univ Liege, B-4000 Liege, Belgium

来源：

OSTEOPOROSIS INTERNATIONAL | 2005年 / 16卷 / 01期

关键词：

D O I：

10.1007/s00198-004-1813-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 5

页数：5

共 28 条

[1] Screening for osteoporosis in postmenopausal women: Recommendations and rationale [J].

Berg, AO ;

Allan, JD ;

Frame, PS ;

Homer, CJ ;

Johnson, MS ;

Klein, JD ;

Lieu, TA ;

Mulrow, CD ;

Orleans, CT ;

Peipert, JF ;

Pender, NJ ;

Siu, AL ;

Teutsch, SM ;

Westhoff, C ;

Woolf, SH .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (06) :526-528

[2] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[3] A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study [J].

Chesnut, CH ;

Silverman, S ;

Andriano, K ;

Genant, H ;

Gimona, A ;

Harris, S ;

Kiel, D ;

LeBoff, M ;

Maricic, M ;

Miller, P ;

Moniz, C ;

Peacock, M ;

Richardson, P ;

Watts, N ;

Baylink, D .

AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :267-276

[4] Report on osteoporosis in the European community: Current status and recommendations for the future [J].

Compston, JE ;

Papapoulos, SE ;

Blanchard, F .

OSTEOPOROSIS INTERNATIONAL, 1998, 8 (06) :531-534

[5] Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].

Cummings, SR ;

Black, DM ;

Thompson, DE ;

Applegate, WB ;

Barrett-Connor, E ;

Musliner, TA ;

Palermo, L ;

Prineas, R ;

Rubin, SM ;

Scott, JC ;

Vogt, T ;

Wallace, R ;

Yates, AJ ;

LaCroix, AZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082

[6] Treatment of postmenopausal osteoporosis [J].

Delmas, PD .

LANCET, 2002, 359 (9322) :2018-2026

[7] The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis [J].

Delmas, PD ;

Calvo, G ;

Boers, M ;

Abadie, E ;

Avouac, B ;

Kahan, A ;

Kaufman, JM ;

Laslop, A ;

Lekkerkerker, JF ;

Nilsson, P ;

Van Zwieten-Boot, B ;

Kreutz, G ;

Reginster, JY .

OSTEOPOROSIS INTERNATIONAL, 2002, 13 (01) :1-5

[8]

Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2, DOI 10.1007/s001980070002

[9] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].

Ettinger, B ;

Black, DM ;

Mitlak, BH ;

Knickerbocker, RK ;

Nickelsen, T ;

Genant, HK ;

Christiansen, C ;

Delmas, PD ;

Zanchetta, JR ;

Stakkestad, J ;

Glüer, CC ;

Krueger, K ;

Cohen, FJ ;

Eckert, S ;

Ensrud, KE ;

Avioli, LV ;

Lips, P ;

Cummings, SR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645

[10] Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial [J].

Harris, ST ;

Watts, NB ;

Genant, HK ;

McKeever, CD ;

Hangartner, T ;

Keller, M ;

Chesnut, CH ;

Brown, J ;

Eriksen, EF ;

Hoseyni, MS ;

Axelrod, DW ;

Miller, PD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14) :1344-1352

← 1 2 3 →